Board of Directors
Jacky Vonderscher has had different leading positions in R&D at Sandoz, Novartis and finally at Roche where he was lately Global Head of Translational Research Sciences. His work was acknowledged in 1995 for the successful development of Sandimmune Neoral®. He is also a co-inventor on the patents of Mycophenolic Acid Sodium salt (Myfortic®) and of Everolimus (Certican® and Affinitor®). Since 2013, Jacky has served as a consultant for Biotech companies. Jacky founded ENYO Pharma SAS in 2014 and serves as its Chief Executive Officer and President.
Jacky holds an engineering degree in biological chemistry from the National Institute of Applied Sciences (INSA-Lyon, France) obtained in 1977 and a PhD in biochemistry from the University of Geneva obtained in 1986.